Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic calcipotriol + betamethasone gel versus Daivobet gel and vehicle in plaque psoriasis
2018-002532-24Phase 3Completed
- Sponsor
- Helm AG
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcipotriol + betamethasone, calcipotriol and betamethasone dipropionate in plaque psoriasis (3 arms), sponsored by Helm AG. Primary endpoint: Mean percentage change from baseline in PASI at Week 4/Day 29. Started Oct 2018; status: completed.
02
Drugs
calcipotriol + betamethasonecalcipotriolbetamethasone dipropionate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2018-002532-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002532-24.